EPISODE · Jan 31, 2025 · 14 MIN
Would Wider Access to GLP-1s Throttle Addiction?
from Cato Podcast
Drugs like Ozempic show potential to help those with addiction with little downside risk. How quickly can their availability be expanded? Nicholas Reville of CASPR makes his case. Hosted on Acast. See acast.com/privacy for more information.
Embed this episode
NOW PLAYING
Would Wider Access to GLP-1s Throttle Addiction?
0:00
14:45
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Cato Podcast?
This episode is 14 minutes long.
When was this Cato Podcast episode published?
This episode was published on January 31, 2025.
Can I download this Cato Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!